High Rate of Awarding Compensation for Claims of Injuries Related to Clinical Trials by Pharmaceutical Companies in Japan: A Questionnaire Survey

• Chieko Kurihara ,

  * E-mail: chieko.kurihara@nifty.ne.jp

  Affiliation Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Chiba, Japan

  ⨯
• Hideo Kusuoka,

  Affiliation National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan

  ⨯
• Shunsuke Ono,

  Affiliation Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan

  ⨯
• Naoko Kakee,

  Affiliation Department of Health Policy, National Center for Child Health and Development, Tokyo, Japan

  ⨯
• Kazuyuki Saito,

  Affiliation Office of OTC/Generic Drugs, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

  ⨯
• Kenji Takehara,

  Affiliation Department of Health Policy, National Center for Child Health and Development, Tokyo, Japan

  ⨯
• Kiyokazu Tsujide,

  Affiliation Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association, Tokyo, Japan

  ⨯
• Yuzo Nabeoka,

  Affiliation Clinical Research Coordination Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan

  ⨯
• Takuya Sakuhiro,

  Affiliation Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan

  ⨯
• Hiroshi Aoki,

  Affiliation Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association, Tokyo, Japan

  ⨯
• Noriko Morishita,

  Affiliation Administration Center for Clinical Trials Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan

  ⨯
• Chieko Suzuki,

  Affiliation Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Hamamatsu, Japan

  ⨯
• Shigeo Kachi,

  Affiliation Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Hamamatsu, Japan

  ⨯
• Emiko Kondo,

  Affiliation Office of Conformity Audit, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

  ⨯
• Yukiko Komori,

  Affiliation Office of New Drug III (CNS/PNS/Anesthesia), Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

  ⨯
• Tetsu Isobe,

  Affiliation Keio Law School, Keio University, Tokyo, Japan

  ⨯
• Shigeru Kageyama,

  Affiliation Division of Clinical Pharmacology and Therapeutics, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
•  [ ... ],
• Hiroshi Watanabe

  Affiliation Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Hamamatsu, Japan

  ⨯
• [ view all ]
• [ view less ]